Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India
· Delayed Price · Currency is INR 1,729.00
-32.10 (-1.82%)
Apr 28, 2026, 3:30 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 131.65 billion as of April 28, 2026. Its market cap has decreased by -10.63% in one year.
Market Cap
131.65B
Enterprise Value
122.67B
Revenue
20.92B
Ranking
n/a
PE Ratio
21.45
Stock Price
1,729.00
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 131.65B, an increase of 2,351,185.17%. That is a compound annual growth rate of 51.62%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alivus Life Sciences | 128.25B |
| Alembic Pharmaceuticals | 150.29B |
| Cohance Lifesciences | 165.31B |
| Strides Pharma Science | 101.26B |
| Eris Lifesciences | 188.17B |
| NATCO Pharma | 195.21B |
| Akums Drugs and Pharmaceuticals | 81.34B |
| Piramal Pharma | 224.11B |